-
Founded in:
2001-02-19 -
Country:
China -
Address:
No. 518, Haozikou Road, Central District, Neijiang City -
Tax NO.:
915110007232358235 -
Registered Funds:
30.28 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Mefenamic acid |
This product is a non-steroidal anti-inflammatory analgesic. It has analgesic, antipyretic and anti-inflammatory effects, and its anti-inflammatory effect is relatively strong. Acute toxicity test results: the oral LD50 of rats is 780mg/kg, and the oral LD50 of mice is 630mg/kg.
More
This product is a non-steroidal anti-inflammatory analgesic. It has analgesic, antipyretic and anti-inflammatory effects, and its anti-inflammatory effect is relatively strong. Acute toxicity test results: the oral LD50 of rats is 780mg/kg, and the oral LD50 of mice is 630mg/kg. |
61-68-7 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clarithromycin |
Clarithromycin belongs to the class of semisynthetic macrolide antibiotics. Clarithromycin binds to the 50S subunit of bacterial ribosomes, thereby inhibiting its protein synthesis and producing an antibacterial effect. In vitro, it has good antibacterial activity against both standard strains and clinical isolates, and has significant antibacterial effects against a variety of aerobic and anaerobic Gram-positive or Gram-negative bacteria. Generally, the minimum inhibitory concentration (MIC) of clarithromycin is the logarithmic dilution concentration of the minimum inhibitory concentration of erythromycin. The results of in vitro pharmacodynamic studies have shown that clarithromycin can inhibit Legionella pneumophila and Mycoplasma pneumoniae, and kill Helicobacter pylori, and its activity under neutral conditions is stronger than that under acidic conditions. In vitro and in vivo data show that objective existence has a significant clinical effect on mycobacteria. In vivo data show that Enterobacter, Pseudomonas and other non-lactose metabolizing Gram-negative bacteria are insensitive to clarithromycin.
More
Clarithromycin belongs to the class of semisynthetic macrolide antibiotics. Clarithromycin binds to the 50S subunit of bacterial ribosomes, thereby inhibiting its protein synthesis and producing an antibacterial effect. In vitro, it has good antibacterial activity against both standard strains and clinical isolates, and has significant antibacterial effects against a variety of aerobic and anaerobic Gram-positive or Gram-negative bacteria. Generally, the minimum inhibitory concentration (MIC) of clarithromycin is the logarithmic dilution concentration of the minimum inhibitory concentration of erythromycin. The results of in vitro pharmacodynamic studies have shown that clarithromycin can inhibit Legionella pneumophila and Mycoplasma pneumoniae, and kill Helicobacter pylori, and its activity under neutral conditions is stronger than that under acidic conditions. In vitro and in vivo data show that objective existence has a significant clinical effect on mycobacteria. In vivo data show that Enterobacter, Pseudomonas and other non-lactose metabolizing Gram-negative bacteria are insensitive to clarithromycin. |
81103-11-9 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| TURMERIC 1G [R] |
|
0 | ||
| CARTHAMI FLOS |
|
0 | ||
| OLIBANUM GUM |
|
8050-07-5 | 0 | |
| MYRRH GUM |
|
9000-45-7 | 0 | |
| D-CAMPHOR |
|
464-49-3 | 1 | |
| Turpentine oil |
|
8006-64-2 | 1 | |
| Ethanol |
|
64-17-5 | 89 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Levamisole hydrochloride |
This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune excitation functions.
More
This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune excitation functions. |
16595-80-5 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Bear bile powder |
Not yet clear
More
Not yet clear |
0 | ||
| ALOE YOHJYU MATSU |
Not yet clear
More
Not yet clear |
0 | ||
| Borneol |
Not yet clear
More
Not yet clear |
507-70-0 | 1 | |
| Borneol |
Not yet clear
More
Not yet clear |
507-70-0 | 1 |